You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

U-MRD

Showing 1 - 25 of 1,385
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer Trial in Chuo-ku

Recruiting
  • HER2-positive Breast Cancer
    • Chuo-ku, Tokyo, Japan
      National Cancer Center Hospital, Japan
    Jun 22, 2022

    Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)

    Terminated
    • Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
    • Badalona, Barcelona, Spain
    • +11 more
    Jul 26, 2022

    MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • MRD and clonal evolution
    • Milano, MI, Italy
    • +13 more
    Nov 2, 2022

    Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Nov 4, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Birmingham, Alabama
    • +8 more
    Jan 24, 2023

    Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse Trial in Italy (Ponatinib)

    Recruiting
    • Philadelphia-Positive ALL
    • Acute Lymphoblastic Leukemia, in Relapse
    • Ancona, Italy
    • +21 more
    Jan 3, 2022

    Mantle Cell Lymphoma Trial in France (Obinutuzumab, Dexamethasone, Aracytine)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Amiens, France
    • +29 more
    Sep 14, 2021

    Acute Lymphoid Leukemia, Philadelphia Chromosome-Negative B-Cell Precursor Trial in Italy (Chemotherapy + Blinatumomab)

    Active, not recruiting
    • Acute Lymphoid Leukemia
    • Philadelphia Chromosome-Negative B-Cell Precursor
    • Chemotherapy + Blinatumomab
    • Ancona, Italy
    • +61 more
    Jan 3, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Greenwich, Connecticut
    • +27 more
    Dec 30, 2022

    Severe Infections on Acute Myeloid Leukemia (AML) Patients

    Recruiting
    • AML
    • Adult
    • Observation
    • Civitanova Marche, Ancona, Italy
    • +45 more
    Dec 31, 2021

    Untreated Philadelphia Positive Acute Lymphoblastic Leukemia, De Novo, Secondary Trial in Italy (Prephase PDN + CY, Cycle 1

    Completed
    • Untreated Philadelphia Positive Acute Lymphoblastic Leukemia
    • +3 more
    • Prephase PDN + CY
    • +10 more
    • Alessandria, Italy
    • +60 more
    Sep 6, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

    Not yet recruiting
    • Lymphoblastic Leukemia in Children
    • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
    • +7 more
    • (no location specified)
    Oct 24, 2023

    Breast Tumors, Nipple Discharge Trial in Guangzhou (Magnetic Resonance Ductography (MRD); and High-Resolution Magnetic Resonance

    Recruiting
    • Breast Neoplasms
    • Nipple Discharge
    • Magnetic Resonance Ductography (MRD); and High-Resolution Magnetic Resonance Ductography (HR-MRD)
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
    Apr 1, 2023

    Chronic Lymphocytic Leukemia Trial in Boston, Hackensack, New York (Ublituximab, Umbralisib, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Boston, Massachusetts
    • +2 more
    Aug 19, 2022

    Mobility Limitation, Overweight or Obesity, Physical Disability Trial in Lawrence (Functional Fitness)

    Recruiting
    • Mobility Limitation
    • +2 more
    • Functional Fitness
    • Lawrence, Kansas
      University of Kansas
    May 26, 2023

    High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

    Not yet recruiting
    • High-Risk de Novo Multiple Myeloma
    • Badalona, Spain
    • +9 more
    Apr 27, 2023

    Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 21, 2023

    Plasma Cell Myeloma Trial in Worldwide (Isatuximab SAR650984, Bortezomib, Lenalidomide)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Isatuximab SAR650984
    • +3 more
    • Fort Myers, Florida
    • +103 more
    Nov 3, 2022

    Acute Myeloid Leukemia in Remission, MDS, Minimal Residual Disease Trial in Germany (Pevonedistat, Azacitidine)

    Active, not recruiting
    • Acute Myeloid Leukemia in Remission
    • +2 more
    • Aachen, Germany
    • +13 more
    Jul 11, 2022

    Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer Trial in Worldwide (Daunorubicin, Prednisolone, Vincristine)

    Recruiting
    • Down Syndrome
    • +2 more
    • Shatin, New Territories, Hong Kong
    • +9 more
    Sep 26, 2022

    Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

    Not yet recruiting
    • Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    T-cell Acute Lymphoblastic Leukemia Trial in Chicago (Daratumumab / Hyaluronidase Injection)

    Recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • Daratumumab / Hyaluronidase Injection
    • Chicago, Illinois
      Northwestern
    Jun 17, 2022

    Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)

    Recruiting
    • Multiple Myeloma
    • Anchorage, Alaska
    • +698 more
    Jan 24, 2023

    Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • Los Angeles, California
    • +17 more
    Jun 6, 2022